Send me more jobs like this

Sr Executive - IT Risk & compliance

Keywords / Skills : ISMS Policies, ISMS, Information Security, Risks Control Matrices, Risk Registers, Risk Analyst, Risk & Compliance, Information Security & IT Controls,

3 - 6 years
Posted: 2018-10-17

Security Analyst
Posted On
17th Oct 2018
Job Description

Must have a strong background in performing risk assessments as part of ISMS implementations. Must have experience in supporting and documenting various audits. Must be willing to travel as part of multiple internal/external/compliance/regulatory audits across the various locations of Biocon. Candidates having certifications such as CISA, ISO 27001:2013 - LA/LI preferred.

Job Responsibilities:

  • Support Biocon Internal Audits relating to ISMS & IT across the locations
  • Support Biocon External Audits, Certification Audits, Vendor Audits & BCP/DR Audits
  • Maintain IT Risk Register & Track Open Risk Items to closure
  • Support review of Biocon Policies, Procedures, SOPS and Audit Documentation
  • Perform Risk Assessments for Biocon Assets, Security Landscape etc.
  • Perform ISMS Surprise audits and Desktop audits across locations
  • Maintain Information Asset Register for Biocon companies
  • Support Organization wide compliance requirements such as EU-GDPR

Role Requirements:

  • Should have in-depth knowledge of Information Security & IT Controls
  • Knowledge of pharma industry and the nature of data handled
  • Knowledge of computer security systems
  • Should be capable of handling confidential information
  • Should be ethical, and be impartial and report all non-compliances
  • Should know how to perform audits
  • Should be able to communicate effectively with strong written communication skills
  • Organizational skills with attention to detail

About Company

Biocon is Asia’s premier biopharmaceutical company that is driven by the vision to make a difference to global healthcare through improved access to high quality, life-saving biotherapeutics by making them affordable for patients across the world.

We have evolved from manufacturing pharmaceuticals like statins and immunosuppresants, to discovering, developing and producing biologics in chronic therapies such as diabetes, oncology and immunology for global markets. This has translated into a diversified and differentiated pipeline of fermentation-derived complex generics, biosimilars that include insulins and monoclonal antibodies, and novel biologics.

Biocon is among the few companies globally to have received approvals for its biosimilars from developed countries like the U.S., EU, Australia and Japan. Our credibility as a serious player in the biosimilars sector was first established with the Japanese approval for Insulin Glargine. The credibility was enhanced when Biocon, along with partner Mylan, became the first globally to get biosimilar Trastuzumab and Pegfilgrastim approved in the U.S. in 2017 and 2018, respectively. We were also among the first few to receive Insulin Glargine approval in Europe and Australia for Insulin Glargine, both in partnership with Mylan. We have also established our presence in key emerging markets through safe, effective and high quality biosimilars including recombinant human insulin.
Similar Jobs
View All Similar Jobs

Walkin for you